| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Pangenomic Health Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.08 |
| 52 Week High | CA$0.70 |
| 52 Week Low | CA$0.05 |
| Beta | 0 |
| 1 Month Change | -66.67% |
| 3 Month Change | -46.67% |
| 1 Year Change | -88.57% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -96.80% |
Recent News & Updates
Recent updates
Shareholder Returns
| NARA | CA Healthcare Services | CA Market | |
|---|---|---|---|
| 7D | -40.7% | 2.4% | -0.6% |
| 1Y | -88.6% | 18.3% | 3.9% |
Return vs Industry: NARA underperformed the Canadian Healthcare Services industry which returned 18.3% over the past year.
Return vs Market: NARA underperformed the Canadian Market which returned 3.9% over the past year.
Price Volatility
| NARA volatility | |
|---|---|
| NARA Average Weekly Movement | 66.6% |
| Healthcare Services Industry Average Movement | 13.5% |
| Market Average Movement | 9.1% |
| 10% most volatile stocks in CA Market | 18.3% |
| 10% least volatile stocks in CA Market | 3.1% |
Stable Share Price: NARA's share price has been volatile over the past 3 months.
Volatility Over Time: NARA's weekly volatility has increased from 38% to 67% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2015 | n/a | Maryam Marissen | www.pangenomic.com |
Pangenomic Health Inc. operates as a precision health company. It develops the Nara App, a mental health app that curates natural remedies for individuals to manage and improve mental wellness; Mindleap, a mental health tracker that offers access to audio content, blogs, and professional services for mental well-being; and MUJN that offers health and wellness insights by combining point-of-care biomarker testing with structured symptom tracking. The company was formerly known as Zetta Capital Corp. and changed its name to PanGenomic Health Inc. in December 2021.
Pangenomic Health Inc. Fundamentals Summary
| NARA fundamental statistics | |
|---|---|
| Market cap | CA$839.74k |
| Earnings (TTM) | -CA$11.78m |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio-0.1x
P/E RatioIs NARA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NARA income statement (TTM) | |
|---|---|
| Revenue | CA$0 |
| Cost of Revenue | CA$808.29k |
| Gross Profit | -CA$808.29k |
| Other Expenses | CA$10.98m |
| Earnings | -CA$11.78m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -1.12 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | -34.3% |
How did NARA perform over the long term?
See historical performance and comparison